Search
Fatigue
go.drugbank.com/conditions/DBCOND0012333Synonyms: Lacking in energy, Lacking in energy (finding)Cognitive Impairment (CI)
go.drugbank.com/conditions/DBCOND0138824Drugs: PiracetamSynonyms: Disturbance in cognitionAzilsartan medoxomil
go.drugbank.com/drugs/DB08822ApprovedInvestigationalIt is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. … [A7354] Many guidelines recommend the use of ARBs as first-line therapy when initiating antihypertensive therapy and indicate that the clinical efficacy of ARBs is comparable to angiotensin-converting
Mixtures: EDARBI CLD®, EDARBI CLD® 40MG/12.5MGCategories: Angiotensin II Type 1 Receptor Blockers, Angiotensin II receptor antagonistsRelapsed Acute Myelogenous Leukemia (AML)
go.drugbank.com/conditions/DBCOND0069493Synonyms: Acute Myelogenous Leukemia in RelapserRNA methyltransferase 2, mitochondrial
go.drugbank.com/bio_entities/BE0020789TargetHumansS-adenosyl-L-methionine-dependent 2'-O-ribose methyltransferase that catalyzes the formation of 2'-O-methyluridine at position 1369 (Um1369) in the 16S mitochondrial large subunit ribosomal RNA (mtLSU … rRNA), a universally conserved modification in the peptidyl transferase domain of the mtLSU rRNA (PubMed:25009282, PubMed:25074936, PubMed:35177605).
Synonyms: 16S rRNA [Um1369] 2'-O-methyltransferase, 16S rRNA (uridine(1369)-2'-O)-methyltransferaseFunction: rRNA (uridine-2'-O-ribose)-methyltransferase activitySleeping Disorders
go.drugbank.com/conditions/DBCOND0148601Synonyms: Disturbance in sleep behavior, NOS, Disturbance in sleep behavior (finding)Etoricoxib
go.drugbank.com/drugs/DB01628ApprovedInvestigationalWithdrawnIt is approved in more than 60 countries worldwide but not in the US. … Etoricoxib is a new COX-2 selective inhibitor.
Synonyms: 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine, 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinylCategories: COX-2 Inhibitors, Cytochrome P-450 SubstratesCephalexin
go.drugbank.com/drugs/DB00567ApprovedInvestigationalVet approved[A179071] Cephalexin is used to treat a number of susceptible bacterial infections through inhibition of cell wall synthesis.[A179083,L6547] Cephalexin was approved by the FDA on 4 January 1971. … Cephalexin is the first of the first generation cephalosporins.[A179071,A179074] This antibiotic contains a beta lactam and a dihydrothiazide.
Synonyms: 7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid, 7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acidInternational brands: L-KeflexMyeloproliferative Disorders
go.drugbank.com/conditions/DBCOND0029888Drugs: ImatinibSynonyms: Myeloproliferative disease, no ICD-O subtype, Chronic myeloproliferative disease, no ICD-O subtype